BBVA
REGN icon

Banco Bilbao Vizcaya Argentaria’s Regeneron Pharmaceuticals REGN Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
22,639
+6,491
+40% +$4.42M 0.09% 164
2026
Q1 		$12.4M Sell
16,148
-19,890
-55% -$15.2M 0.09% 166
2025
Q4 		$27.8M Sell
36,038
-1,587
-4% -$1.08M 0.19% 83
2025
Q3 		$21.2M Sell
37,625
-51
-0.1% -$28.8K 0.16% 113
2025
Q2 		$19.8M Sell
37,676
-492
-1% -$275K 0.18% 104
2025
Q1 		$24.2M Buy
38,168
+649
+2% +$446K 0.24% 82
2024
Q4 		$26.8M Sell
37,519
-179
-0.5% -$150K 0.28% 70
2024
Q3 		$39.6M Sell
37,698
-3,900
-9% -$4.34M 0.4% 48
2024
Q2 		$43.7M Buy
41,598
+950
+2% +$921K 0.46% 33
2024
Q1 		$39.1M Buy
40,648
+528
+1% +$502K 0.45% 42
2023
Q4 		$35.2M Sell
40,120
-559
-1% -$460K 0.42% 52
2023
Q3 		$33.4M Sell
40,679
-806
-2% -$633K 0.45% 50
2023
Q2 		$29.8M Buy
41,485
+1,472
+4% +$1.13M 0.39% 60
2023
Q1 		$32.9M Sell
40,013
-544
-1% -$410K 0.41% 60
2022
Q4 		$29.3M Buy
40,557
+973
+2% +$718K 0.43% 54
2022
Q3 		$27.2M Sell
39,584
-3,965
-9% -$2.5M 0.44% 53
2022
Q2 		$25.7M Buy
43,549
+11,078
+34% +$7.2M 0.39% 61
2022
Q1 		$22.8M Buy
32,471
+2,925
+10% +$1.85M 0.31% 75
2021
Q4 		$18.9M Buy
29,546
+19,497
+194% +$12M 0.25% 80
2021
Q3 		$6.1M Buy
10,049
+3,030
+43% +$1.88M 0.1% 185
2021
Q2 		$3.75M Buy
7,019
+4,206
+150% +$2.13M 0.07% 261
2021
Q1 		$1.33M Sell
2,813
-1,963
-41% -$956K 0.03% 439
2020
Q4 		$2.31M Buy
4,776
+544
+13% +$294K 0.05% 304
2020
Q3 		$2.37M Buy
4,232
+398
+10% +$241K 0.07% 242
2020
Q2 		$2.39M Buy
3,834
+2,881
+302% +$1.64M 0.08% 217
2020
Q1 		$465K Buy
953
+78
+9% +$32.2K 0.02% 502
2019
Q4 		$328K Buy
+875
New +$294K 0.01% 596

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's REGN Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria increased its Regeneron Pharmaceuticals (REGN) stake by 40% in Q2 2026, buying an estimated $4.42M and bringing the position to 22,639 shares worth $14.1M. The position accounts for 0.09% of the portfolio, ranked #164.

Banco Bilbao Vizcaya Argentaria first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $43.7M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 22,639 shares of Regeneron Pharmaceuticals worth $14.1M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria bought 6,491 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.42M.
  • Regeneron Pharmaceuticals made up 0.09% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #164 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Regeneron Pharmaceuticals position peaked at $43.7M in Q2 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.